On October 11, Walgreens Boots Alliance (“WBA”) announced the acceleration of its acquisition of the remaining 45% interest in CareCentrix for $392 million. WBA had already acquired a 55% interest in CareCentrix for $330 million in August 2022. The deal is set to close in March 2023 and comes on the heels of WBA’s announcement in September that it was acquiring the remaining 30% stake in Shields Health Solutions for $1.4 billion. CareCentrix operates within the home care space, and its services include home nursing, durable medical equipment, home infusion and in-home palliative care services. CareCentrix will continue to operate as a separate business under WBA’s US Healthcare unit after the acquisition is complete.